BioCardia (BCDA) Earnings Date & Reports

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BCDA is expected to report earnings to rise 118.75% to -17 cents per share on August 12

Q2'26

Est.

$-0.17

Q2'24

Beat

by $0.12

Q1'24

Beat

by $0.11

Q4'23

Beat

by $0.02

Q3'23

Beat

by $0.02

The last earnings report on August 13 showed earnings per share of -7 cents, beating the estimate of -20 cents. With 1.12M shares outstanding, the current market capitalization sits at 14.39M.

View a ticker or compare two or three

Compare

BCDA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BCDA